about
Challenges of drug-resistant malariaNanoparticulate adjuvants and delivery systems for allergen immunotherapyAnti-HIV-1 nanotherapeutics: promises and challenges for the futureCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Quantum dots as a platform for nanoparticle drug delivery vehicle designQuantum dots for tracking dendritic cells and priming an immune response in vitro and in vivoVaccines: the Fourth CenturyIsolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-IIIInduction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.Nanotechnology and HIV: potential applications for treatment and prevention.Programming the magnitude and persistence of antibody responses with innate immunity.Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine.A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coliNanoparticles and the immune systemNew directions in nicotine vaccine design and use.Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental designChronic inflammatory responses to microgel-based implant coatings.Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitisPlasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunizationTherapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasisNanomedicine in the Management of Microbial Infection - Overview and PerspectivesNanoparticle approaches against bacterial infectionsBiomaterials for nanoparticle vaccine delivery systems.Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelScientific overview: 2013 BBC plenary symposium on tobacco addiction.An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccinesNanotechnology in dermatology.Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development.Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodiesApplications of viral nanoparticles in medicine.Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responsesVaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis.In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid APlasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth
P2860
Q21032482-282BCDD8-F516-467E-A4E6-096872ADC0C4Q26825418-0C053FBB-4B58-41E8-B766-AFE4994F96DEQ26828464-85ABC2EA-059B-4F7C-8851-C6962E6284ADQ26830028-952F37A5-B698-4867-940F-51EF7D43EE0EQ26996556-C6584E17-A3D2-40F8-A440-E8266CAECABFQ27438175-BB3746C5-1838-4D3C-8D1A-9ED5C5B997CCQ27490454-E387A756-86F8-4D42-A769-B7EDAC7726DDQ28474859-834704EF-0350-4C9B-BC3B-EBCEEBC86574Q30382453-5B3FA82D-CE87-4B3C-AECB-CD280CC91CC7Q30393980-D40ADBE7-8D7A-4A80-9FBE-5FF41F317CE8Q30400144-D9EA504A-452A-4A9E-AF0D-D5D20A0E79BFQ30412800-D7E06BF4-099E-493B-8392-DF77D94A1F69Q30431343-BBEFF55C-FDE9-48E1-9DFC-5C1FAAB9F94DQ33485233-F0A99FD6-E689-4BAB-9314-4CCC4874D8A8Q33634320-F3276113-27FD-44E4-AA83-29DA39BF6C1BQ33719424-5FD18ABE-3C58-40FB-8200-DC3CD068E1C4Q33746872-1D117BA5-BBC4-4D96-A085-710870ABAEDCQ33779670-DCEB2CF5-8958-4007-B4CB-0EF883C3AE2BQ33872401-FDA0A62D-3A35-40F6-A6F4-14B4D2F02ED8Q33934146-C0BD1150-D509-4E8D-968E-C45AC40DA5B5Q33993714-E4437D01-96BE-4EA2-AA82-35F31A29EAEFQ34053031-FC0CACB1-2580-4F79-BEB7-F559F06BCF5EQ34119427-6A6A2384-D687-4212-AE0E-9539884A8FDFQ34206187-1BCAA07B-F603-4FD8-A9CC-53C4B57B8566Q34245494-C30FAAEA-67A8-4FBC-928A-6F1FA141FEACQ34339159-6C85AE70-A4BC-413B-96AD-301911EB4BF4Q34345012-4FBBC48D-4F07-4347-9DB4-1517A941EA70Q34398787-56473FE8-6FB0-4BDC-B983-4186F67C4757Q34487271-B33B3067-E6A6-41B4-9A2F-AEC8E60F5F63Q35100779-A0E66F23-AE98-420E-AF52-A2F186480D48Q35120307-17FB3AD4-C590-42C6-8857-539BEAC5B437Q35165017-21453B25-D7FE-4328-82FA-EB7129705D20Q35272875-CC28F540-2CFC-4DC5-8549-2FCACFC0D5D4Q35318380-DF52C7E2-64DF-4527-9191-4A279C3BD952Q35456892-79B9BDEF-CC98-466A-AE1D-8E97A585FF36Q35501007-9FDF1AF7-4D42-4E37-BD0F-F9A95D62AD21Q35740218-2645A224-5457-4D8B-B8FF-25EE2E4CCA49Q35977996-3B53110B-F255-4644-A5B6-3D754D81A002Q36189723-977BAA20-CAAD-42CD-83C0-6FE65DA68FA2Q36322686-69BACE42-AE50-4280-9DDA-ED8AE53B829B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanotechnology in vaccine delivery.
@en
Nanotechnology in vaccine delivery.
@nl
type
label
Nanotechnology in vaccine delivery.
@en
Nanotechnology in vaccine delivery.
@nl
prefLabel
Nanotechnology in vaccine delivery.
@en
Nanotechnology in vaccine delivery.
@nl
P2093
P1476
Nanotechnology in vaccine delivery.
@en
P2093
C Russell Middaugh
Cory Berkland
Laura J Peek
P304
P356
10.1016/J.ADDR.2007.05.017
P407
P577
2008-02-07T00:00:00Z